Active 0 6 0 6 O
systemic 7 15 7 15 B-chronic_disease
viral 16 21 16 21 I-chronic_disease
, 21 22 21 22 O
bacterial 23 32 23 32 B-chronic_disease
or 33 35 33 35 O
fungal 36 42 36 42 B-chronic_disease
infection 43 52 43 52 I-chronic_disease
requiring 53 62 53 62 O
treatment 63 72 63 72 B-treatment

Adults 0 6 73 79 O
greater 7 14 80 87 O
than 15 19 88 92 O
or 20 22 93 95 O
equal 23 28 96 101 O
to 29 31 102 104 O
18 32 34 105 107 B-lower_bound

Age 0 3 108 111 B-age
greater 4 11 112 119 O
than 12 16 120 124 O
or 17 19 125 127 O
equal 20 25 128 133 O
to 26 28 134 136 O
18 29 31 137 139 B-lower_bound
years 32 37 140 145 I-lower_bound

Baseline 0 8 146 154 O
LVEF 9 13 155 159 B-clinical_variable
by 14 16 160 162 O
2D 17 19 163 165 B-treatment
Echocardiogram 20 34 166 180 I-treatment
greater 35 42 181 188 O
than 43 47 189 193 O
or 48 50 194 196 O
equal 51 56 197 202 O
to 57 59 203 205 O
53 60 62 206 208 B-lower_bound
% 62 63 208 209 I-lower_bound

Chemistry 0 9 210 219 O
parameters 10 20 220 230 O
: 20 21 230 231 O
Creatinine 22 32 232 242 B-clinical_variable
less 33 37 243 247 O
than 38 42 248 252 O
1.5 43 46 253 256 B-upper_bound
mg 47 49 257 259 I-upper_bound
/ 49 50 259 260 I-upper_bound
dL 50 52 260 262 I-upper_bound
, 52 53 262 263 O
SGOT 54 58 264 268 B-clinical_variable
and 59 62 269 272 O
SGPT 63 67 273 277 B-clinical_variable
less 68 72 278 282 O
than 73 77 283 287 O
or 78 80 288 290 O
equal 81 86 291 296 O
to 87 89 297 299 O
3X 90 92 300 302 B-upper_bound
the 93 96 303 306 I-upper_bound
upper 97 102 307 312 I-upper_bound
limits 103 109 313 319 I-upper_bound
of 110 112 320 322 I-upper_bound
normal 113 119 323 329 I-upper_bound
and 120 123 330 333 O
total 124 129 334 339 B-clinical_variable
bilirubin 130 139 340 349 I-clinical_variable
less 140 144 350 354 O
than 145 149 355 359 O
or 150 152 360 362 O
equal 153 158 363 368 O
to 159 161 369 371 O
1.5 162 165 372 375 B-upper_bound
mg 166 168 376 378 I-upper_bound
/ 168 169 378 379 I-upper_bound
dl 169 171 379 381 I-upper_bound
, 171 172 381 382 O
Alk 173 176 383 386 B-clinical_variable
PO4 177 180 387 390 I-clinical_variable
less 181 185 391 395 O
than 186 190 396 400 O
or 191 193 401 403 O
equal 194 199 404 409 O
to 200 202 410 412 O
3X 203 205 413 415 O
the 206 209 416 419 O
upper 210 215 420 425 O
limits 216 222 426 432 O
of 223 225 433 435 O
normal 226 232 436 442 O
( 233 234 443 444 O
except 234 240 444 450 O
for 241 244 451 454 O
patients 245 253 455 463 O
with 254 258 464 468 O
documented 259 269 469 479 O
metastatic 270 280 480 490 B-cancer
disease 281 288 491 498 I-cancer
to 289 291 499 501 O
bone 292 296 502 506 O
and/or 297 303 507 513 O
liver 304 309 514 519 O
) 309 310 519 520 O

Chemistry 0 9 521 530 O
parameters 10 20 531 541 O
: 20 21 541 542 O
Creatinine 22 32 543 553 B-clinical_variable
less 33 37 554 558 O
than 38 42 559 563 O
mg 43 45 564 566 O
/ 45 46 566 567 O
dL 46 48 567 569 O
, 48 49 569 570 O
SGOT 50 54 571 575 B-clinical_variable
and 55 58 576 579 O
SGPT 59 63 580 584 B-clinical_variable
less 64 68 585 589 O
than 69 73 590 594 O
or 74 76 595 597 O
equal 77 82 598 603 O
to 83 85 604 606 O
3X 86 88 607 609 B-upper_bound
ULN 89 92 610 613 I-upper_bound
, 92 93 613 614 O
total 94 99 615 620 O
bilirubin 100 109 621 630 B-clinical_variable
less 110 114 631 635 O
than 115 119 636 640 O
or 120 122 641 643 O
equal 123 128 644 649 O
to 129 131 650 652 O
1.5X 132 136 653 657 B-upper_bound
ULN 137 140 658 661 I-upper_bound
and 141 144 662 665 O
Alk 145 148 666 669 B-clinical_variable
PO4 149 152 670 673 I-clinical_variable
less 153 157 674 678 O
than 158 162 679 683 O
or 163 165 684 686 O
equal 166 171 687 692 O
to 172 174 693 695 O
3X 175 177 696 698 O
ULN 178 181 699 702 O
( 182 183 703 704 O
except 183 189 704 710 O
for 190 193 711 714 O
patients 194 202 715 723 O
with 203 207 724 728 O
documented 208 218 729 739 O
metastatic 219 229 740 750 B-cancer
disease 230 237 751 758 I-cancer
to 238 240 759 761 O
bone 241 245 762 766 O
and/or 246 252 767 773 O
liver 253 258 774 779 O
) 258 259 779 780 O

Clinically 0 10 781 791 O
significant 11 22 792 803 O
cardiac 23 30 804 811 B-chronic_disease
dysfunction 31 42 812 823 I-chronic_disease
defined 43 50 824 831 O
as 51 53 832 834 O
a 54 55 835 836 O
history 56 63 837 844 O
of 64 66 845 847 O
> 67 68 848 849 O
= 68 69 849 850 O
NYHA 70 74 851 855 B-clinical_variable
Class 75 80 856 861 I-clinical_variable
II 81 83 862 864 I-clinical_variable
symptoms 84 92 865 873 O
, 92 93 873 874 O
angina 94 100 875 881 B-chronic_disease
, 100 101 881 882 O
congestive 102 112 883 893 B-chronic_disease
heart 113 118 894 899 I-chronic_disease
failure 119 126 900 907 I-chronic_disease
, 126 127 907 908 O
myocardial 128 138 909 919 B-chronic_disease
infarction 139 149 920 930 I-chronic_disease
, 149 150 930 931 O
arrhythmias 151 162 932 943 B-chronic_disease
or 163 165 944 946 O
cardiac 166 173 947 954 O
dysfunction 174 185 955 966 O
requiring 186 195 967 976 O
treatment 196 205 977 986 B-treatment
or 206 208 987 989 O
discontinuation 209 224 990 1005 O
of 225 227 1006 1008 O
chemotherapy 228 240 1009 1021 B-treatment

Cumulative 0 10 1022 1032 O
doxorubicin 11 22 1033 1044 B-treatment
dose 23 27 1045 1049 O
> 28 29 1050 1051 O
= 29 30 1051 1052 O
400mg 31 36 1053 1058 B-lower_bound
/ 36 37 1058 1059 I-lower_bound
m^2 37 40 1059 1062 I-lower_bound
( 41 42 1063 1064 O
> 42 43 1064 1065 O
450 43 46 1065 1068 B-lower_bound
mg 47 49 1069 1071 I-lower_bound
/ 49 50 1071 1072 I-lower_bound
m^2 50 53 1072 1075 I-lower_bound
for 54 57 1076 1079 O
malignant 58 67 1080 1089 B-cancer
soft 68 72 1090 1094 I-cancer
tissue 73 79 1095 1101 I-cancer
and 80 83 1102 1105 O
bone 84 88 1106 1110 B-cancer
tumor 89 94 1111 1116 I-cancer
patients 95 103 1117 1125 O
) 103 104 1125 1126 O
or 105 107 1127 1129 O
cumulative 108 118 1130 1140 O
epirubicin 119 129 1141 1151 B-treatment
dose 130 134 1152 1156 O
> 135 136 1157 1158 O
= 136 137 1158 1159 O
800mg 138 143 1160 1165 B-lower_bound
/ 143 144 1165 1166 I-lower_bound
m^2 144 147 1166 1169 I-lower_bound

Greater 0 7 1170 1177 O
than 8 12 1178 1182 O
or 13 15 1183 1185 O
equal 16 21 1186 1191 O
to 22 24 1192 1194 O
1 25 26 1195 1196 B-lower_bound
week 27 31 1197 1201 I-lower_bound
since 32 37 1202 1207 O
receipt 38 45 1208 1215 O
of 46 48 1216 1218 O
standard 49 57 1219 1227 B-treatment
or 58 60 1228 1230 O
investigational 61 76 1231 1246 B-treatment
HER2- 77 82 1247 1252 I-treatment
directed 83 91 1253 1261 I-treatment
therapy 92 99 1262 1269 I-treatment
for 100 103 1270 1273 O
metastatic 104 114 1274 1284 B-cancer
or 115 117 1285 1287 O
recurrent 118 127 1288 1297 O
disease 128 135 1298 1305 O

Greater 0 7 1306 1313 O
than 8 12 1314 1318 O
or 13 15 1319 1321 O
equal 16 21 1322 1327 O
to 22 24 1328 1330 O
1 25 26 1331 1332 B-lower_bound
week 27 31 1333 1337 I-lower_bound
since 32 37 1338 1343 O
standard 38 46 1344 1352 O
or 47 49 1353 1355 O
investigational 50 65 1356 1371 B-treatment
treatment 66 75 1372 1381 I-treatment
for 76 79 1382 1385 O
metastatic 80 90 1386 1396 B-cancer
disease 91 98 1397 1404 I-cancer

Greater 0 7 1405 1412 O
than 8 12 1413 1417 O
or 13 15 1418 1420 O
equal 16 21 1421 1426 O
to 22 24 1427 1429 O
6 25 26 1430 1431 B-lower_bound
weeks 27 32 1432 1437 I-lower_bound
s 33 34 1438 1439 O
/ 34 35 1439 1440 O
p 35 36 1440 1441 O
primary 37 44 1442 1449 O
surgery 45 52 1450 1457 B-treatment
with 53 57 1458 1462 I-treatment
curative 58 66 1463 1471 I-treatment
intent 67 73 1472 1478 I-treatment

Hematologic 0 11 1479 1490 O
parameters 12 22 1491 1501 O
: 22 23 1501 1502 O
ANC 24 27 1503 1506 B-clinical_variable
> 28 29 1507 1508 O
= 29 30 1508 1509 O
1000 31 35 1510 1514 B-lower_bound
cells 36 41 1515 1520 I-lower_bound
/ 41 42 1520 1521 I-lower_bound
mm^3 42 46 1521 1525 I-lower_bound
, 46 47 1525 1526 O
ALC 48 51 1527 1530 B-clinical_variable
> 52 53 1531 1532 O
= 53 54 1532 1533 O
300 55 58 1534 1537 B-lower_bound
cells 59 64 1538 1543 I-lower_bound
/ 64 65 1543 1544 I-lower_bound
mm^3 65 69 1544 1548 I-lower_bound
, 69 70 1548 1549 O
Hemoglobin 71 81 1550 1560 B-clinical_variable
> 82 83 1561 1562 O
= 83 84 1562 1563 O
9.0 85 88 1564 1567 B-lower_bound
gm 89 91 1568 1570 I-lower_bound
/ 91 92 1570 1571 I-lower_bound
dL 92 94 1571 1573 I-lower_bound
, 94 95 1573 1574 O
WBC 96 99 1575 1578 B-clinical_variable
> 100 101 1579 1580 O
= 101 102 1580 1581 O
2,500 103 108 1582 1587 B-lower_bound
cells 109 114 1588 1593 I-lower_bound
/ 114 115 1593 1594 I-lower_bound
mm^3 115 119 1594 1598 I-lower_bound
, 119 120 1598 1599 O
platelet 121 129 1600 1608 B-clinical_variable
count 130 135 1609 1614 I-clinical_variable
> 136 137 1615 1616 O
= 137 138 1616 1617 O
75,000 139 145 1618 1624 B-lower_bound
/ 145 146 1624 1625 I-lower_bound
mm^3 146 150 1625 1629 I-lower_bound
, 150 151 1629 1630 O
PT 152 154 1631 1633 B-clinical_variable
/ 154 155 1633 1634 O
PTT 155 158 1634 1637 B-clinical_variable
less 159 163 1638 1642 O
than 164 168 1643 1647 O
or 169 171 1648 1650 O
equla 172 177 1651 1656 O
to1.5X 178 184 1657 1663 B-upper_bound
the 185 188 1664 1667 I-upper_bound
upper 189 194 1668 1673 I-upper_bound
limits 195 201 1674 1680 I-upper_bound
of 202 204 1681 1683 I-upper_bound
normal 205 211 1684 1690 I-upper_bound

Hematologic 0 11 1691 1702 O
parameters 12 22 1703 1713 O
: 22 23 1713 1714 O
ANC 24 27 1715 1718 B-clinical_variable
> 28 29 1719 1720 O
= 29 30 1720 1721 O
1000 31 35 1722 1726 B-lower_bound
cells 36 41 1727 1732 I-lower_bound
/ 41 42 1732 1733 I-lower_bound
mm^3 42 46 1733 1737 I-lower_bound
, 46 47 1737 1738 O
ALC 48 51 1739 1742 B-clinical_variable
> 52 53 1743 1744 O
= 53 54 1744 1745 O
300 55 58 1746 1749 B-lower_bound
cells 59 64 1750 1755 I-lower_bound
/ 64 65 1755 1756 I-lower_bound
mm^3 65 69 1756 1760 I-lower_bound
, 69 70 1760 1761 O
absolute 71 79 1762 1770 B-clinical_variable
Hemoglobin 80 90 1771 1781 I-clinical_variable
> 91 92 1782 1783 O
= 92 93 1783 1784 O
9.0 93 96 1784 1787 B-lower_bound
gm 97 99 1788 1790 I-lower_bound
/ 99 100 1790 1791 I-lower_bound
dL 100 102 1791 1793 I-lower_bound
, 102 103 1793 1794 O
WBC 104 107 1795 1798 B-clinical_variable
> 108 109 1799 1800 O
= 109 110 1800 1801 O
2500 110 114 1801 1805 B-lower_bound
cells 115 120 1806 1811 I-lower_bound
/ 120 121 1811 1812 I-lower_bound
mm3 121 124 1812 1815 I-lower_bound
, 124 125 1815 1816 O
platelet 126 134 1817 1825 B-clinical_variable
count 135 140 1826 1831 I-clinical_variable
> 141 142 1832 1833 O
= 142 143 1833 1834 O
75,000 143 149 1834 1840 B-lower_bound
/ 149 150 1840 1841 I-lower_bound
mm^3 150 154 1841 1845 I-lower_bound
, 154 155 1845 1846 O
PT 156 158 1847 1849 B-clinical_variable
/ 158 159 1849 1850 I-clinical_variable
PTT 159 162 1850 1853 I-clinical_variable
1.5X 163 167 1854 1858 O
the 168 171 1859 1862 O
upper 172 177 1863 1868 O
limits 178 184 1869 1875 O
of 185 187 1876 1878 O
normal 188 194 1879 1885 O

History 0 7 1886 1893 O
of 8 10 1894 1896 O
changes 11 18 1897 1904 O
in 19 21 1905 1907 O
baseline 22 30 1908 1916 O
LVEF 31 35 1917 1921 B-clinical_variable
that 36 40 1922 1926 O
occurred 41 49 1927 1935 O
during 50 56 1936 1942 O
prior 57 62 1943 1948 B-treatment
treatment 63 72 1949 1958 I-treatment
with 73 77 1959 1963 O
anti 78 82 1964 1968 B-treatment
- 82 83 1968 1969 I-treatment
HER2 83 87 1969 1973 I-treatment
treatment 88 97 1974 1983 I-treatment

May 0 3 1984 1987 O
or 4 6 1988 1990 O
may 7 10 1991 1994 O
not 11 14 1995 1998 O
have 15 19 1999 2003 O
received 20 28 2004 2012 O
adjuvant 29 37 2013 2021 B-treatment
radiotherapy 38 50 2022 2034 I-treatment
or 51 53 2035 2037 O
chemotherapy 54 66 2038 2050 B-treatment
based 67 72 2051 2056 O
on 73 75 2057 2059 O
pathologic 76 86 2060 2070 O
risk 87 91 2071 2075 O
per 92 95 2076 2079 O
NCCN 96 100 2080 2084 O
guidelines 101 111 2085 2095 O

May 0 3 2096 2099 O
or 4 6 2100 2102 O
may 7 10 2103 2106 O
not 11 14 2107 2110 O
have 15 19 2111 2115 O
received 20 28 2116 2124 O
neoadjuvant 29 40 2125 2136 B-treatment
cisplatin 41 50 2137 2146 O
- 50 51 2146 2147 O
based 51 56 2147 2152 O
combination 57 68 2153 2164 O
chemotherapy 69 81 2165 2177 B-treatment
per 82 85 2178 2181 O
NCCN 86 90 2182 2186 O
guidelines 91 101 2187 2197 O

Naive 0 5 2198 2203 O
to 6 8 2204 2206 O
trastuzumab 9 20 2207 2218 B-treatment
( 21 22 2219 2220 I-treatment
Herceptin(TM 22 34 2220 2232 I-treatment
) 34 35 2232 2233 I-treatment
) 35 36 2233 2234 O
, 36 37 2234 2235 O
pertuzumab 38 48 2236 2246 B-treatment
( 49 50 2247 2248 I-treatment
Perjeta(TM 50 60 2248 2258 I-treatment
) 60 61 2258 2259 I-treatment
) 61 62 2259 2260 O
and 63 66 2261 2264 O
lapatinib 67 76 2265 2274 B-treatment
( 77 78 2275 2276 I-treatment
Tykerb(TM 78 87 2276 2285 I-treatment
) 87 88 2285 2286 I-treatment
) 88 89 2286 2287 O
, 89 90 2287 2288 O
ado 91 94 2289 2292 B-treatment
- 94 95 2292 2293 I-treatment
trastuzumab 95 106 2293 2304 I-treatment
emtansine 107 116 2305 2314 I-treatment
( 117 118 2315 2316 I-treatment
Kadcyla(TM 118 128 2316 2326 I-treatment
) 128 129 2326 2327 I-treatment
) 129 130 2327 2328 O
or 131 133 2329 2331 O
other 134 139 2332 2337 O
HER2 140 144 2338 2342 B-treatment
- 144 145 2342 2343 I-treatment
directed 145 153 2343 2351 I-treatment
therapies 154 163 2352 2361 I-treatment

Negative 0 8 2362 2370 O
serology 9 17 2371 2379 O
for 18 21 2380 2383 O
anti 22 26 2384 2388 O
- 26 27 2388 2389 O
HIV-1/2 27 34 2389 2396 B-chronic_disease
and 35 38 2397 2400 O
anti 39 43 2401 2405 O
- 43 44 2405 2406 O
HTLV 44 48 2406 2410 B-chronic_disease
1/2 49 52 2411 2414 O

Negative 0 8 2415 2423 O
serology 9 17 2424 2432 B-treatment
for 18 21 2433 2436 O
hepatitis 22 31 2437 2446 B-chronic_disease
B 32 33 2447 2448 I-chronic_disease
and 34 37 2449 2452 I-chronic_disease
C 38 39 2453 2454 I-chronic_disease
unless 40 46 2455 2461 O
the 47 50 2462 2465 O
result 51 57 2466 2472 O
is 58 60 2473 2475 O
consistent 61 71 2476 2486 O
with 72 76 2487 2491 O
prior 77 82 2492 2497 B-treatment
vaccination 83 94 2498 2509 I-treatment
or 95 97 2510 2512 O
prior 98 103 2513 2518 O
infection 104 113 2519 2528 B-chronic_disease
with 114 118 2529 2533 O
full 119 123 2534 2538 O
recovery 124 132 2539 2547 O

Negative 0 8 2548 2556 B-clinical_variable
serum 9 14 2557 2562 I-clinical_variable
beta 15 19 2563 2567 I-clinical_variable
HCG 20 23 2568 2571 I-clinical_variable
if 24 26 2572 2574 O
female 27 33 2575 2581 B-gender
and 34 37 2582 2585 O
of 38 40 2586 2588 O
childbearing 41 53 2589 2601 O
potential 54 63 2602 2611 O

Negative 0 8 2612 2620 B-pregnancy
serum 9 14 2621 2626 I-pregnancy
beta 15 19 2627 2631 I-pregnancy
HCG 20 23 2632 2635 I-pregnancy
if 24 26 2636 2638 O
of 27 29 2639 2641 O
childbearing 30 42 2642 2654 O
potential 43 52 2655 2664 O

Patients 0 8 2665 2673 O
with 9 13 2674 2678 O
active 14 20 2679 2685 O
CNS 21 24 2686 2689 B-cancer
metastases 25 35 2690 2700 I-cancer
or 36 38 2701 2703 O
leptomeningeal 39 53 2704 2718 B-cancer
involvement 54 65 2719 2730 O
by 66 68 2731 2733 O
tumor 69 74 2734 2739 B-cancer
( 75 76 2740 2741 O
patients 76 84 2741 2749 O
with 85 89 2750 2754 O
a 90 91 2755 2756 O
history 92 99 2757 2764 O
of 100 102 2765 2767 O
brain 103 108 2768 2773 B-cancer
metastases 109 119 2774 2784 I-cancer
who 120 123 2785 2788 O
have 124 128 2789 2793 O
been 129 133 2794 2798 O
successfully 134 146 2799 2811 O
treated 147 154 2812 2819 O
for 155 158 2820 2823 O
brain 159 164 2824 2829 B-chronic_disease
metastasis 165 175 2830 2840 I-chronic_disease
by 176 178 2841 2843 O
surgery 179 186 2844 2851 B-treatment
or 187 189 2852 2854 O
radiation 190 199 2855 2864 B-treatment
and 200 203 2865 2868 O
who 204 207 2869 2872 O
have 208 212 2873 2877 O
not 213 216 2878 2881 O
had 217 220 2882 2885 O
any 221 224 2886 2889 O
evidence 225 233 2890 2898 O
of 234 236 2899 2901 O
the 237 240 2902 2905 O
new 241 244 2906 2909 O
or 245 247 2910 2912 O
progressive 248 259 2913 2924 O
CNS 260 263 2925 2928 B-chronic_disease
disease 264 271 2929 2936 I-chronic_disease
fot 272 275 2937 2940 O
more 276 280 2941 2945 O
than 281 285 2946 2950 O
12 286 288 2951 2953 B-lower_bound
months 289 295 2954 2960 I-lower_bound
are 296 299 2961 2964 O
eligible 300 308 2965 2973 O
) 308 309 2973 2974 O

Patients 0 8 2975 2983 O
with 9 13 2984 2988 O
breast 14 20 2989 2995 B-cancer
cancer 21 27 2996 3002 I-cancer
that 28 32 3003 3007 O
is 33 35 3008 3010 O
known 36 41 3011 3016 O
to 42 44 3017 3019 O
be 45 47 3020 3022 O
HER2 48 52 3023 3027 O
1 53 54 3028 3029 O
+ 54 55 3029 3030 O
or 56 58 3031 3033 O
2 59 60 3034 3035 O
+ 60 61 3035 3036 O
by 62 64 3037 3039 O
IHC 65 68 3040 3043 B-treatment
or 69 71 3044 3046 O
with 72 76 3047 3051 O
a 77 78 3052 3053 O
Vysis 79 84 3054 3059 B-clinical_variable
FISH 85 89 3060 3064 I-clinical_variable
result 90 96 3065 3071 O
of 97 99 3072 3074 O
1.8 100 103 3075 3078 B-lower_bound
- 104 105 3079 3080 O
less 106 110 3081 3085 O
than 111 115 3086 3090 O
2.2 116 119 3091 3094 B-upper_bound

Patients 0 8 3095 3103 O
with 9 13 3104 3108 O
breast 14 20 3109 3115 B-cancer
cancer 21 27 3116 3122 I-cancer
, 27 28 3122 3123 O
gastric 29 36 3124 3131 B-cancer
, 36 37 3131 3132 O
gastroesophageal 38 54 3133 3149 B-cancer
junction 55 63 3150 3158 I-cancer
or 64 66 3159 3161 O
other 67 72 3162 3167 O
cancers 73 80 3168 3175 B-cancer
with 81 85 3176 3180 O
1 86 87 3181 3182 O
+ 87 88 3182 3183 O
to 89 91 3184 3186 O
3 92 93 3187 3188 O
+ 93 94 3188 3189 O
HER2 95 99 3190 3194 B-clinical_variable
/ 99 100 3194 3195 O
neu 100 103 3195 3198 O
expression 104 114 3199 3209 O
by 115 117 3210 3212 O
IHC 118 121 3213 3216 O
or 122 124 3217 3219 O
a 125 126 3220 3221 O
Vysis 127 132 3222 3227 B-clinical_variable
FISH 133 137 3228 3232 I-clinical_variable
result 138 144 3233 3239 I-clinical_variable
> 145 146 3240 3241 O
2.2 147 150 3242 3245 B-lower_bound

Patients 0 8 3246 3254 O
with 9 13 3255 3259 O
inadequate 14 24 3260 3270 O
bilateral 25 34 3271 3280 B-chronic_disease
peripheral 35 45 3281 3291 I-chronic_disease
venous 46 52 3292 3298 I-chronic_disease
or 53 55 3299 3301 O
central 56 63 3302 3309 O
venous 64 70 3310 3316 O
catheter 71 79 3317 3325 O
access 80 86 3326 3332 O
for 87 90 3333 3336 O
the 91 94 3337 3340 O
required 95 103 3341 3349 O
apheresis 104 113 3350 3359 B-treatment
to 114 116 3360 3362 O
allow 117 122 3363 3368 O
generation 123 133 3369 3379 O
of 134 136 3380 3382 O
the 137 140 3383 3386 O
autologous 141 151 3387 3397 B-treatment
AdHER2 152 158 3398 3404 I-treatment
DC 159 161 3405 3407 I-treatment
vaccine 162 169 3408 3415 I-treatment
product 170 177 3416 3423 O

Patients 0 8 3424 3432 O
with 9 13 3433 3437 O
ovarian 14 21 3438 3445 B-cancer
, 21 22 3445 3446 O
cervical 23 31 3447 3455 B-cancer
, 31 32 3455 3456 O
colon 33 38 3457 3462 B-cancer
, 38 39 3462 3463 O
gastric 40 47 3464 3471 B-cancer
/ 47 48 3471 3472 O
gastroesophageal 48 64 3472 3488 B-cancer
junction 65 73 3489 3497 I-cancer
, 73 74 3497 3498 O
non 75 78 3499 3502 B-cancer
- 78 79 3502 3503 I-cancer
small 79 84 3503 3508 I-cancer
cell 85 89 3509 3513 I-cancer
lung 90 94 3514 3518 I-cancer
, 94 95 3518 3519 O
renal 96 101 3520 3525 B-cancer
cell 102 106 3526 3530 I-cancer
, 106 107 3530 3531 O
bladder 108 115 3532 3539 B-cancer
, 115 116 3539 3540 O
malignant 117 126 3541 3550 B-cancer
soft 127 131 3551 3555 I-cancer
tissue 132 138 3556 3562 I-cancer
and 139 142 3563 3566 O
bone 143 147 3567 3571 B-cancer
tumor 148 153 3572 3577 I-cancer
prostate 154 162 3578 3586 I-cancer
cancer 163 169 3587 3593 I-cancer
or 170 172 3594 3596 O
other 173 178 3597 3602 O
solid 179 184 3603 3608 B-cancer
tumors 185 191 3609 3615 I-cancer
that 192 196 3616 3620 O
is 197 199 3621 3623 O
known 200 205 3624 3629 O
to 206 208 3630 3632 O
be 209 211 3633 3635 O
HER2 212 216 3636 3640 O
1 217 218 3641 3642 O
+ 218 219 3642 3643 O
, 219 220 3643 3644 O
2 221 222 3645 3646 O
+ 222 223 3646 3647 O
or 224 226 3648 3650 O
3 227 228 3651 3652 O
+ 228 229 3652 3653 O
by 230 232 3654 3656 O
IHC 233 236 3657 3660 B-clinical_variable
OR 237 239 3661 3663 O
have 240 244 3664 3668 O
a 245 246 3669 3670 O
Vysis 247 252 3671 3676 B-clinical_variable
FISH 253 257 3677 3681 I-clinical_variable
result 258 264 3682 3688 O
greater 265 272 3689 3696 O
than 273 277 3697 3701 O
or 278 280 3702 3704 O
equal 281 286 3705 3710 O
to 287 289 3711 3713 O
1.8 290 293 3714 3717 B-lower_bound

Performance 0 11 3718 3729 B-clinical_variable
Status 12 18 3730 3736 I-clinical_variable
: 18 19 3736 3737 O
ECOG 20 24 3738 3742 B-clinical_variable
0 25 26 3743 3744 B-lower_bound
- 26 27 3744 3745 O
1 27 28 3745 3746 B-upper_bound

Perormance 0 10 3747 3757 B-clinical_variable
Status 11 17 3758 3764 I-clinical_variable
: 17 18 3764 3765 O
ECOG 19 23 3766 3770 B-clinical_variable
0 24 25 3771 3772 B-lower_bound
- 25 26 3772 3773 O
1 26 27 3773 3774 B-upper_bound

Pregnant 0 8 3775 3783 B-pregnancy
women 9 14 3784 3789 B-gender
are 15 18 3790 3793 O
excluded 19 27 3794 3802 O
from 28 32 3803 3807 O
this 33 37 3808 3812 O
study 38 43 3813 3818 O
because 44 51 3819 3826 O
AdHER 52 57 3827 3832 B-treatment
DC 58 60 3833 3835 I-treatment
vaccine 61 68 3836 3843 I-treatment
may 69 72 3844 3847 O
have 73 77 3848 3852 O
the 78 81 3853 3856 O
potential 82 91 3857 3866 O
for 92 95 3867 3870 O
teratogenic 96 107 3871 3882 B-treatment
or 108 110 3883 3885 O
abortifacient 111 124 3886 3899 O
effects 125 132 3900 3907 O

Recurrent 0 9 3908 3917 O
or 10 12 3918 3920 O
progressive 13 24 3921 3932 B-chronic_disease
disease 25 32 3933 3940 I-chronic_disease
on 33 35 3941 3943 O
prior 36 41 3944 3949 O
standard 42 50 3950 3958 O
therapies 51 60 3959 3968 B-treatment
with 61 65 3969 3973 O
known 66 71 3974 3979 O
clinical 72 80 3980 3988 O
benefit 81 88 3989 3996 O
with 89 93 3997 4001 O
the 94 97 4002 4005 O
exception 98 107 4006 4015 O
of 108 110 4016 4018 O
adjuvant 111 119 4019 4027 O
bladder 120 127 4028 4035 B-cancer
cancer 128 134 4036 4042 I-cancer
population 135 145 4043 4053 O

Recurrent 0 9 4054 4063 O
or 10 12 4064 4066 O
progressive 13 24 4067 4078 O
metastatic 25 35 4079 4089 B-cancer
disease 36 43 4090 4097 I-cancer
after 44 49 4098 4103 O
standard 50 58 4104 4112 O
of 59 61 4113 4115 O
care 62 66 4116 4120 O
HER2 67 71 4121 4125 B-clinical_variable
- 71 72 4125 4126 O
targeted 72 80 4126 4134 B-treatment
therapies 81 90 4135 4144 I-treatment

Stable 0 6 4145 4151 O
, 6 7 4151 4152 O
concurrent 8 18 4153 4163 O
use 19 22 4164 4167 O
of 23 25 4168 4170 O
tamoxifen 26 35 4171 4180 B-treatment
or 36 38 4181 4183 O
aromatase 39 48 4184 4193 B-treatment
inhibitors 49 59 4194 4204 I-treatment
for 60 63 4205 4208 O
hormone 64 71 4209 4216 B-cancer
receptor 72 80 4217 4225 I-cancer
positive 81 89 4226 4234 I-cancer
breast 90 96 4235 4241 I-cancer
cancer 97 103 4242 4248 I-cancer

Stable 0 6 4249 4255 O
, 6 7 4255 4256 O
concurrent 8 18 4257 4267 O
use 19 22 4268 4271 O
of 23 25 4272 4274 O
tamoxifen 26 35 4275 4284 B-treatment
or 36 38 4285 4287 O
aromatase 39 48 4288 4297 B-treatment
inhibitors 49 59 4298 4308 I-treatment
for 60 63 4309 4312 O
hormone 64 71 4313 4320 O
receptor 72 80 4321 4329 O
positive 81 89 4330 4338 O
breast 90 96 4339 4345 B-cancer
cancer 97 103 4346 4352 I-cancer
are 104 107 4353 4356 O
allowed 108 115 4357 4364 O

Status 0 6 4365 4371 O
- 6 7 4371 4372 O
post 7 11 4372 4376 O
primary 12 19 4377 4384 O
cystectomy 20 30 4385 4395 B-treatment
with 31 35 4396 4400 O
curative 36 44 4401 4409 O
intent 45 51 4410 4416 O

Tumor 0 5 4417 4422 B-cancer
stage 6 11 4423 4428 B-cancer
T3a 12 15 4429 4432 I-cancer
, 15 16 4432 4433 O
T3b 17 20 4434 4437 B-cancer
, 20 21 4437 4438 O
T4a 22 25 4439 4442 B-cancer
, 25 26 4442 4443 O
T4b 27 30 4444 4447 B-cancer
and 31 34 4448 4451 O
any 35 38 4452 4455 O
node 39 43 4456 4460 O
positive 44 52 4461 4469 O
disease 53 60 4470 4477 O
regardless 61 71 4478 4488 O
of 72 74 4489 4491 O
tumor 75 80 4492 4497 B-cancer
stage 81 86 4498 4503 O

Tumors 0 6 4504 4510 B-cancer
that 7 11 4511 4515 O
are 12 15 4516 4519 O
HER2 16 20 4520 4524 B-clinical_variable
1 21 22 4525 4526 B-lower_bound
+ 22 23 4526 4527 O
, 23 24 4527 4528 O
2 25 26 4529 4530 O
+ 26 27 4530 4531 O
or 28 30 4532 4534 O
3 31 32 4535 4536 B-upper_bound
+ 32 33 4536 4537 O
by 34 36 4538 4540 O
IHC 37 40 4541 4544 B-clinical_variable
or 41 43 4545 4547 O
have 44 48 4548 4552 O
a 49 50 4553 4554 O
Vysis 51 56 4555 4560 B-clinical_variable
FISH 57 61 4561 4565 I-clinical_variable
result 62 68 4566 4572 I-clinical_variable
greater 69 76 4573 4580 O
than 77 81 4581 4585 O
1.8 82 85 4586 4589 B-lower_bound

Use 0 3 4590 4593 O
of 4 6 4594 4596 O
any 7 10 4597 4600 O
standard 11 19 4601 4609 O
chemotherapy 20 32 4610 4622 B-treatment
or 33 35 4623 4625 O
other 36 41 4626 4631 O
investigational 42 57 4632 4647 B-treatment
agent(s 58 65 4648 4655 I-treatment
) 65 66 4655 4656 I-treatment
within 67 73 4657 4663 O
1 74 75 4664 4665 B-upper_bound
week 76 80 4666 4670 I-upper_bound
of 81 83 4671 4673 O
study 84 89 4674 4679 O
enrollment 90 100 4680 4690 O

Use 0 3 4691 4694 O
of 4 6 4695 4697 O
systemic 7 15 4698 4706 B-treatment
corticosteroid 16 30 4707 4721 I-treatment
therapy 31 38 4722 4729 I-treatment
within 39 45 4730 4736 O
2 46 47 4737 4738 B-upper_bound
weeks 48 53 4739 4744 I-upper_bound
of 54 56 4745 4747 O
study 57 62 4748 4753 O
enrollment 63 73 4754 4764 O
, 73 74 4764 4765 O
including 75 84 4766 4775 O
patients 85 93 4776 4784 O
receiving 94 103 4785 4794 O
replacement 104 115 4795 4806 B-treatment
corticosteroid 116 130 4807 4821 I-treatment
therapy 131 138 4822 4829 I-treatment

Willingness 0 11 4830 4841 O
of 12 14 4842 4844 O
female 15 21 4845 4851 B-gender
and 22 25 4852 4855 I-gender
male 26 30 4856 4860 I-gender
subjects 31 39 4861 4869 I-gender
to 40 42 4870 4872 O
use 43 46 4873 4876 B-contraception_consent
effective 47 56 4877 4886 I-contraception_consent
contraception 57 70 4887 4900 I-contraception_consent
e.g. 71 75 4901 4905 O
oral 76 80 4906 4910 B-contraception_consent
contraceptives 81 95 4911 4925 I-contraception_consent
, 95 96 4925 4926 O
barrier 97 104 4927 4934 B-contraception_consent
device 105 111 4935 4941 I-contraception_consent
, 111 112 4941 4942 O
intrauterine 113 125 4943 4955 B-contraception_consent
device 126 132 4956 4962 I-contraception_consent
, 132 133 4962 4963 O
or 134 136 4964 4966 O
condoms 137 144 4967 4974 B-contraception_consent
, 144 145 4974 4975 O
during 146 152 4976 4982 O
the 153 156 4983 4986 O
study 157 162 4987 4992 O
and 163 166 4993 4996 O
for 167 170 4997 5000 O
three 171 176 5001 5006 B-upper_bound
months 177 183 5007 5013 I-upper_bound
following 184 193 5014 5023 O
the 194 197 5024 5027 O
last 198 202 5028 5032 O
dose 203 207 5033 5037 O
of 208 210 5038 5040 O
study 211 216 5041 5046 B-treatment
vaccine 217 224 5047 5054 I-treatment

Willingness 0 11 5055 5066 O
of 12 14 5067 5069 O
female 15 21 5070 5076 B-gender
subjects 22 30 5077 5085 I-gender
to 31 33 5086 5088 O
use 34 37 5089 5092 B-contraception_consent
effective 38 47 5093 5102 I-contraception_consent
contraception 48 61 5103 5116 I-contraception_consent

with 0 4 5117 5121 O
HER2 5 9 5122 5126 B-cancer
+ 9 10 5126 5127 O
bladder 11 18 5128 5135 B-cancer
cancer 19 25 5136 5142 I-cancer
in 26 28 5143 5145 O
the 29 32 5146 5149 O
adjuvant 33 41 5150 5158 O
setting 42 49 5159 5166 O
( 50 51 5167 5168 O
adjuvant 51 59 5168 5176 O
bladder 60 67 5177 5184 O
cancer 68 74 5185 5191 O
patients 75 83 5192 5200 O
) 83 84 5200 5201 O

with 0 4 5202 5206 O
malignant 5 14 5207 5216 O
soft 15 19 5217 5221 O
tissue 20 26 5222 5228 O
and 27 30 5229 5232 O
bone 31 35 5233 5237 B-cancer
tumors 36 42 5238 5244 I-cancer
and 43 46 5245 5248 O
recurrent 47 56 5249 5258 O
or 57 59 5259 5261 O
progressive 60 71 5262 5273 O
, 71 72 5273 5274 O
metastatic 73 83 5275 5285 B-cancer
solid 84 89 5286 5291 B-cancer
tumors 90 96 5292 5298 I-cancer
who 97 100 5299 5302 O
have 101 105 5303 5307 O
progressed 106 116 5308 5318 O
on 117 119 5319 5321 O
standard 120 128 5322 5330 B-treatment
therapies 129 138 5331 5340 I-treatment
with 139 143 5341 5345 O
known 144 149 5346 5351 O
benefit 150 157 5352 5359 O
but 158 161 5360 5363 O
for 162 165 5364 5367 O
whom 166 170 5368 5372 O
anti 171 175 5373 5377 B-treatment
- 175 176 5377 5378 I-treatment
HER2 176 180 5378 5382 I-treatment
therapy 181 188 5383 5390 I-treatment
is 189 191 5391 5393 O
not 192 195 5394 5397 O
clinically 196 206 5398 5408 O
indicated 207 216 5409 5418 O

